Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries
about
G-protein Coupled Receptor Signaling in Pluripotent Stem Cell-derived Cardiovascular Cells: Implications for Disease ModelingRole of angiotensin AT(2) receptors in natriuresis: Intrarenal mechanisms and therapeutic potentialThe kallikrein-kinin system in diabetic nephropathyAT2 receptor activities and pathophysiological implicationsMetabolic actions of angiotensin II and insulin: a microvascular endothelial balancing actIntermittent losartan administration triggers cardiac post-conditioning in isolated rat hearts: role of BK2 receptorsA nonpeptide angiotensin II type 2 receptor agonist prevents renal inflammation in early diabetes.Losartan increases muscle insulin delivery and rescues insulin's metabolic action during lipid infusion via microvascular recruitment.The intrarenal renin-angiotensin and dopaminergic systems: control of renal sodium excretion and blood pressureAT2 receptors: beneficial counter-regulatory role in cardiovascular and renal functionCandesartan acutely recruits skeletal and cardiac muscle microvasculature in healthy humans.Angiotensin II receptors modulate muscle microvascular and metabolic responses to insulin in vivoAngiotensin II type 1 and type 2 receptors regulate basal skeletal muscle microvascular volume and glucose use.Hypertension management and microvascular insulin resistance in diabetesMicrovascular vasodilator properties of the angiotensin II type 2 receptor in a mouse model of type 1 diabetes.Angiotensin II stimulates thick ascending limb NO production via AT(2) receptors and Akt1-dependent nitric-oxide synthase 3 (NOS3) activationCardiac phenotype and angiotensin II levels in AT1a, AT1b, and AT2 receptor single, double, and triple knockouts.Angiotensin II type 2 receptor ligand PD123319 attenuates hyperoxia-induced lung and heart injury at a low dose in newborn rats.Angiotensin II mediates the high-glucose-induced endothelial-to-mesenchymal transition in human aortic endothelial cells.Upregulation of ERK1/2-eNOS via AT2 receptors decreases the contractile response to angiotensin II in resistance mesenteric arteries from obese rats.Renal fibrosis.Emerging role of angiotensin type 2 receptor (AT2R)/Akt/NO pathway in vascular smooth muscle cell in the hyperthyroidism.Angiotensin II acutely decreases myocardial stiffness: a novel AT1, PKC and Na+/H+ exchanger-mediated effect.Differential mechanisms of ang (1-7)-mediated vasodepressor effect in adult and aged candesartan-treated ratsPharmacological characterisation of capsaicin-induced relaxations in human and porcine isolated arteriesAngiotensin II regulation of ovine fetoplacental artery endothelial functions: interactions with nitric oxide.International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].Angiotensin II type 1 and type 2 receptor expression in circulating monocytes of diabetic and hypercholesterolemic patients over 3-month rosuvastatin treatment.Why are mineralocorticoid receptor antagonists cardioprotective?The role of angiotensin II type 1 receptor blockers in the prevention and management of diabetes mellitus.Angiotensin II AT(2) receptor decreases AT(1) receptor expression and function via nitric oxide/cGMP/Sp1 in renal proximal tubule cells from Wistar-Kyoto rats.Vascular angiotensin AT2 receptors in hypertension and ageing.Vasomotor regulation of coronary microcirculation by oxidative stress: role of arginase.Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury.Angiotensin II type-2 receptor-specific effects on the cardiovascular system.Impact of AT2-receptor stimulation on vascular biology, kidney function, and blood pressure.Adapter proteins and promoter regulation of the angiotensin AT2 receptor--implications for cardiac pathophysiology.The apelinergic system: a promising therapeutic target.New insights into angiotensin receptor actions: from blood pressure to aging.Blood pressure and renal hemodynamic effects of angiotensin fragments.
P2860
Q26772221-BF5702A4-2733-48A6-ABDF-80F29E17A689Q26825135-D0A61F0C-83E4-4BD0-8463-B496863AE747Q26827473-D25FEF89-D689-4987-8055-8FB99C421CB2Q26829592-8ED4B99D-C876-4BE3-92DE-20500527B349Q28390079-94FE7E5E-BA69-4490-919A-738E10D485CBQ28539671-A2FE5DEE-D8D6-4486-B7A0-B944E47CAB24Q30300953-432208EB-A9DB-4D7D-AB53-005B3B6F5BD8Q30414452-B1D4B47E-E0C3-48C2-BEC4-19AA6008F4E7Q30414541-3A03EA61-6B0A-48C4-A893-B4025E40F540Q30415577-AA74300E-B280-44B4-B88A-A1D0F96CF2FCQ30418516-1AF79DAB-8DA7-4581-80FC-C59D36AD9FCDQ30424204-ECC9C78A-5C2F-431B-B90B-B2AA389E0C0EQ30433343-7D82CE7C-5867-4C58-8A78-5950FE41E765Q30433501-F994688B-8264-4755-8A2A-8A40E51CFA66Q30843430-067C1EF4-AA53-4853-8D6B-685C64E59777Q33832746-ADC8B818-59AD-46BD-8FAD-7C284E829287Q33844005-6D5EA1D7-BA8F-4AB0-AC06-19FC7440E96FQ34001678-0DB11B49-F76E-46C0-8782-F9E7AD1DC927Q34060789-6E8E5F2D-D6B7-4940-893C-96BF7CA13BD7Q34110231-6CED6AD7-CA97-4409-9785-80147E758958Q34417331-0716D407-88E7-4365-AE62-B16510C96C5CQ34700791-BA72CB9F-4975-4876-BCD2-C2A0E7E59800Q35545375-CA52A8A5-98A9-4A4A-9154-B0E90CCB7FB3Q35606516-F78A1DCD-B837-400A-8487-0C866E1865B6Q35884256-69064FF9-44B8-443E-B52E-1A7D2A3F0CBFQ36080082-A6DC1724-B27A-4B5A-AE78-DB7D4CEA8AEAQ36241932-B5BFB7E8-DE02-4DA0-B194-B5F7987A88C0Q36548151-1427A21D-4158-4977-B82B-F9FF76B016FAQ36639935-AE94ADC8-DE5D-4BCB-8A64-CA1BDD855E26Q36909521-558EFC56-001B-4E69-901A-978590EE7D2BQ36994675-EFEC4241-E836-4A3B-A176-B35356965A4CQ37097104-3094C0F1-A539-41D8-BAA7-77FEFE807702Q37102697-7108C1BF-ED4E-48BE-8BAE-81E0E2492E8BQ37147092-973D9A40-1421-43E5-8A50-CFFD20EA595CQ37339329-B0138DBD-EF6B-4B41-9E9C-0047473DF599Q37416298-F88CB938-0A96-419B-B3C6-19A122C54ABFQ37598488-5338C5DB-68B2-4357-87F0-C8BF74B3DE8FQ37720708-935DFB64-7688-4A64-9B59-5FFCC71A53B0Q37809435-6B9F8093-7A2C-4762-A6D7-2E2731E9A255Q37853834-85C71324-4224-4FB8-9835-18CF31B7665D
P2860
Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries
@ast
Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries
@en
Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries
@en-gb
Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries
@nl
type
label
Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries
@ast
Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries
@en
Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries
@en-gb
Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries
@nl
prefLabel
Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries
@ast
Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries
@en
Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries
@en-gb
Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries
@nl
P2093
P1433
P1476
Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries
@en
P2093
A H Jan Danser
Catherine Chapuis Bernasconi
Ingrid M Garrelds
Jorge P van Kats
Lucienne Juillerat-Jeanneret
Pramod R Saxena
Wendy W Batenburg
P304
P356
10.1161/01.CIR.0000128696.12245.57
P407
P577
2004-05-18T00:00:00Z